Endocrinology, Vol 129, 1402-1408, Copyright © 1991 by Endocrine Society

ARTICLES

Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice

WY Chen, ME White, TE Wagner and JJ Kopchick
Department of Zoology, Ohio University, Athens.

A dwarf transgenic mouse (DTM) line has been established in which mice express relatively high levels of a mutated bovine (b) GH gene. This bGH analog binds to mouse liver membrane preparations with an affinity similar to that of wild-type bGH. The mean growth ratio of these mice is approximately 0.7 relative to that of their nontransgenic littermates. Serum insulin-like growth factor-I (IGF-I) levels of DTM were found to be approximately half those in nontransgenic littermates. Liver GH receptor levels were up-regulated in DTM or wild-type bGH transgenic mice. Pituitary GH levels were negatively correlated with serum IGF-I concentrations. Wild-type bGH transgenic mice contain relatively high serum IGF-I and low pituitary GH levels, whereas DTM possess low serum IGF-I and high pituitary GH levels. The decrease in serum IGF-I resulting from the interaction between the bGH analog, the endogenous mouse GH, and GH receptor(s) apparently leads to a dwarf phenotype. These data suggest that this bGH analog has uncoupled GH ligand-receptor binding from IGF-I production and acts as a functional antagonist to the action of endogenous mGH.

This article has been cited by other articles:

				J.R. Smid, J.E. Rowland, W.G. Young, K.T. Coschigano, J.J. Kopchick, and M.J. Waters Mouse Molar Dentin Size/Shape is Dependent on Growth Hormone Status J. Dent. Res., May 1, 2007; 86(5): 463 - 468. [Abstract] [Full Text] [PDF]

				D. L. Kleinberg, W. Ruan, D. Yee, K. T. Kovacs, and S. Vidal Insulin-Like Growth Factor (IGF)-I Controls Prostate Fibromuscular Development: IGF-I Inhibition Prevents Both Fibromuscular and Glandular Development in Eugonadal Mice Endocrinology, March 1, 2007; 148(3): 1080 - 1088. [Abstract] [Full Text] [PDF]

				J. F. Langenheim, D. Tan, A. M. Walker, and W. Y. Chen Two Wrongs Can Make a Right: Dimers of Prolactin and Growth Hormone Receptor Antagonists Behave as Agonists Mol. Endocrinol., March 1, 2006; 20(3): 661 - 674. [Abstract] [Full Text] [PDF]

				G. O. Ramirez-Yanez, J. R. Smid, W. G. Young, and M. J. Waters Influence of growth hormone on the craniofacial complex of transgenic mice Eur J Orthod, October 1, 2005; 27(5): 494 - 500. [Abstract] [Full Text] [PDF]

				P. A. Pennisi, J. J. Kopchick, S. Thorgeirsson, D. LeRoith, and S. Yakar Role of Growth Hormone (GH) in Liver Regeneration Endocrinology, October 1, 2004; 145(10): 4748 - 4755. [Abstract] [Full Text] [PDF]

				K. Iida, J. P. del Rincon, D.-S. Kim, E. Itoh, K. T. Coschigano, J. J. Kopchick, and M. O. Thorner Regulation of full-length and truncated growth hormone (GH) receptor by GH in tissues of lit/lit or bovine GH transgenic mice Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E566 - E573. [Abstract] [Full Text] [PDF]

				C. W. E. Meyer, D. Korthaus, W. Jagla, E. Cornali, J. Grosse, H. Fuchs, M. Klingenspor, S. Roemheld, M. Tschop, G. Heldmaier, et al. A Novel Missense Mutation in the Mouse Growth Hormone Gene Causes Semidominant Dwarfism, Hyperghrelinemia, and Obesity Endocrinology, May 1, 2004; 145(5): 2531 - 2541. [Abstract] [Full Text] [PDF]

				A. F. Muller, J. J. Kopchick, A. Flyvbjerg, and A. J. van der Lely Growth Hormone Receptor Antagonists J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1503 - 1511. [Full Text] [PDF]

				K. Iida, J. P. Del Rincon, D.-S. Kim, E. Itoh, R. Nass, K. T. Coschigano, J. J. Kopchick, and M. O. Thorner Tissue-Specific Regulation of Growth Hormone (GH) Receptor and Insulin-Like Growth Factor-I Gene Expression in the Pituitary and Liver of GH-Deficient (lit/lit) Mice and Transgenic Mice that Overexpress Bovine GH (bGH) or a bGH Antagonist Endocrinology, April 1, 2004; 145(4): 1564 - 1570. [Abstract] [Full Text] [PDF]

				J.R. Smid, J.E. Rowland, W.G. Young, T.J. Daley, K.T. Coschigano, J.J. Kopchick, and M.J. Waters Mouse Cellular Cementum is Highly Dependent on Growth Hormone Status J. Dent. Res., January 1, 2004; 83(1): 35 - 39. [Abstract] [Full Text] [PDF]

				K. T. Coschigano, A. N. Holland, M. E. Riders, E. O. List, A. Flyvbjerg, and J. J. Kopchick Deletion, But Not Antagonism, of the Mouse Growth Hormone Receptor Results in Severely Decreased Body Weights, Insulin, and Insulin-Like Growth Factor I Levels and Increased Life Span Endocrinology, September 1, 2003; 144(9): 3799 - 3810. [Abstract] [Full Text] [PDF]

				Y. Li, J. R. Knapp, and J. J. Kopchick Enlargement of Interscapular Brown Adipose Tissue in Growth Hormone Antagonist Transgenic and in Growth Hormone Receptor Gene-Disrupted Dwarf Mice Experimental Biology and Medicine, February 1, 2003; 228(2): 207 - 215. [Abstract] [Full Text] [PDF]

				J. J. Kopchick, C. Parkinson, E. C. Stevens, and P. J. Trainer Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly Endocr. Rev., October 1, 2002; 23(5): 623 - 646. [Abstract] [Full Text] [PDF]

				G. Zhang, W. Li, L. Holle, N. Chen, and W. Y. Chen A Novel Design of Targeted Endocrine and Cytokine Therapy for Breast Cancer Clin. Cancer Res., April 1, 2002; 8(4): 1196 - 1205. [Abstract] [Full Text] [PDF]

				Y. Li, B. Kelder, and J. J. Kopchick Identification, Isolation, and Cloning of Growth Hormone (GH)-Inducible Interscapular Brown Adipose Complementary Deoxyribonucleic Acid from GH Antagonist Mice Endocrinology, July 1, 2001; 142(7): 2937 - 2945. [Abstract] [Full Text] [PDF]

				R. J. M. Ross, K. C. Leung, M. Maamra, W. Bennett, N. Doyle, M. J. Waters, and K. K. Y. Ho Binding and Functional Studies with the Growth Hormone Receptor Antagonist, B2036-PEG (Pegvisomant), Reveal Effects of Pegylation and Evidence That It Binds to a Receptor Dimer J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1716 - 1723. [Abstract] [Full Text]

				K. K. Kaulsay, T. Zhu, W. F. Bennett, K.-O. Lee, and P. E. Lobie The Effects of Autocrine Human Growth Hormone (hGH) on Human Mammary Carcinoma Cell Behavior Are Mediated via the hGH Receptor Endocrinology, February 1, 2001; 142(2): 767 - 777. [Abstract] [Full Text] [PDF]

				N. D. Turner, J. R. Knapp, F. M. Byers, and J. J. Kopchick Physical and Mechanical Characteristics of Tibias from Transgenic Mice Expressing Mutant Bovine Growth Hormone Genes Experimental Biology and Medicine, February 1, 2001; 226(2): 133 - 139. [Abstract] [Full Text]

				S. H. Zarkesh-Esfahani, O. Kolstad, R. A. Metcalfe, P. F. Watson, S. Von Laue, S. Walters, A. Revhaug, A. P. Weetman, and R. J. M. Ross High-Dose Growth Hormone Does Not Affect Proinflammatory Cytokine (Tumor Necrosis Factor-{alpha}, Interleukin-6, and Interferon-{gamma}) Release from Activated Peripheral Blood Mononuclear Cells or after Minimal to Moderate Surgical Stress J. Clin. Endocrinol. Metab., September 1, 2000; 85(9): 3383 - 3390. [Abstract] [Full Text]

				K. T. Coschigano, D. Clemmons, L. L. Bellush, and J. J. Kopchick Assessment of Growth Parameters and Life Span of GHR/BP Gene-Disrupted Mice Endocrinology, July 1, 2000; 141(7): 2608 - 2613. [Abstract] [Full Text] [PDF]

				S. L. Asa, K. T. Coschigano, L. Bellush, J. J. Kopchick, and S. Ezzat Evidence for Growth Hormone (GH) Autoregulation in Pituitary Somatotrophs in GH Antagonist-Transgenic Mice and GH Receptor-Deficient Mice Am. J. Pathol., March 1, 2000; 156(3): 1009 - 1015. [Abstract] [Full Text] [PDF]

				L. L. Bellush, S. Doublier, A. N. Holland, L. J. Striker, G. E. Striker, and J. J. Kopchick Protection against Diabetes-Induced Nephropathy in Growth Hormone Receptor/Binding Protein Gene-Disrupted Mice Endocrinology, January 1, 2000; 141(1): 163 - 168. [Abstract] [Full Text] [PDF]

				W. Y. Chen, P. Ramamoorthy, N.-y. Chen, R. Sticca, and T. E. Wagner A Human Prolactin Antagonist, hPRL-G129R, Inhibits Breast Cancer Cell Proliferation through Induction of Apoptosis Clin. Cancer Res., November 1, 1999; 5(11): 3583 - 3593. [Abstract] [Full Text] [PDF]

				W. Ruan, L. Powell-Braxton, J. J. Kopchick, and D. L. Kleinberg Evidence That Insulin-Like Growth Factor I and Growth Hormone Are Required for Prostate Gland Development Endocrinology, May 1, 1999; 140(5): 1984 - 1989. [Abstract] [Full Text]

				N. D. Turner, J. R. Knapp, F. M. Byers, and J. J. Kopchick Expression of Mutant Bovine Growth Hormone Genes in Mice Perturbs Age-Related Nutrient Utilization Patterns J. Nutr., March 1, 1998; 128(3): 520 - 524. [Abstract] [Full Text]

				Y. Zhou, B. C. Xu, H. G. Maheshwari, L. He, M. Reed, M. Lozykowski, S. Okada, L. Cataldo, K. Coschigamo, T. E. Wagner, et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse) PNAS, November 25, 1997; 94(24): 13215 - 13220. [Abstract] [Full Text] [PDF]

				Y. Wei, J. Li, W. Y. Chen, and T. E. Wagner Human Growth Hormone Antagonist (G120R) Delivered by a Murine Yolk Sac Cell-Derived Mini-Organ Decreases the Growth Rate of Mice Stem Cells, September 1, 1997; 15(5): 364 - 367. [Abstract] [Full Text]

				L. E. Smith, J. J. Kopchick, W. Chen, J. Knapp, F. Kinose, D. Daley, E. Foley, R. G. Smith, and J. M. Schaeffer Essential Role of Growth Hormone in Ischemia-Induced Retinal Neovascularization Science, June 13, 1997; 276(5319): 1706 - 1709. [Abstract] [Full Text]

				N.-y. Chen, W. Y. Chen, and J. J. Kopchick Liver and Kidney Growth Hormone (GH) Receptors Are Regulated Differently in Diabetic GH and GH Antagonist Transgenic Mice Endocrinology, May 1, 1997; 138(5): 1988 - 1994. [Abstract] [Full Text] [PDF]

				P. A. Harding, X. Wang, S. Okada, W. Y. Chen, W. Wan, and J. J. Kopchick Growth Hormone (GH) and a GH Antagonist Promote GH Receptor Dimerization and Internalization J. Biol. Chem., March 22, 1996; 271(12): 6708 - 6712. [Abstract] [Full Text] [PDF]